Stanphl Quick Update On Two Microcap Positions

Excerpt from the Stanphyl Capital letter to investors for the month of October 2017 discussing their long positions in two micro-cap plays. Stanphyl was profiled in the second edition of HVS and has had some of the best picks among all the funds we have profiled with 200%+ returns on some pitches. [timeless] And now for the long positions… We continue to own medical equipment maker Please login to view Continue Reading →

Boyles Fund — Q3 2017 Letter to Partners

Unfortunately, we can’t publish the whole Boyles Fund Q3 letter due to compliance reasons but here’s an extract and commentary on some positions: Dear Partners, Our slightly negative performance during the quarter was driven largely by a meaningful decline in our largest holding. Our cash balance has also begun to move back up, as we exited a smaller position and received some dividends during the quarter. We discuss this and other Continue Reading →